Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04872478
Title Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Meryx, Inc.
Age Groups: child | senior | adult
Covered Countries USA

Additional content available in CKB BOOST